Navigation Links
ResMed Announces Deferred Conversions in Connection With Stock Split
Date:8/13/2010

SYDNEY, Aug. 12 /PRNewswire-FirstCall/ -- ResMed, Inc. (NYSE: http://photos.prnewswire.com/prnh/20100203/RESMEDLOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20100203/RESMEDLOGO)

As advised in the Company's 6 August announcement:

  • Stockholders of record on the New York Stock Exchange at the close of trading on August 17, 2010 will receive one additional share of common stock for each share held on that date.  The common stock will be distributed to shareholders on or about August 30, 2010, by ResMed's NYSE transfer agent, American Stock Transfer and Trust Company, LLC.  The common stock is expected to begin trading on a post-split basis on the NYSE beginning on August 31, 2010, or one day following the distribution date.
  • Holders of CHESS Depositary Interests (CDIs) on the Australian Stock Exchange will also receive a bonus issue of one additional CDI for every CDI held on the ASX record date of August 18, 2010. Unlike the shares on the NYSE, the existing CDIs will be quoted on an "ex-bonus" basis on August 12, 2010 on the ASX (ASX: RMD), and bonus CDI's will be quoted on a deferred settlement basis (ASX: RMDBN).  The bonus CDIs will be distributed by ResMed's ASX share registry, Computershare Limited, on or about August 31, 2010, and normal trading will begin on the following day.

Due to the difference in market practice between the NYSE and ASX, ResMed applied for and has been granted a waiver of rules 13.9.4  and 13.9.9 of the ASX Settlement Operating Rules, allowing it to defer the processing of conversions (transmutations) between its Common Stock and CDI registers that are lodged in the period from and including 12 August 2010 up to and including 31 August 2010.  Therefore, no conversions (transmutat
'/>"/>

SOURCE ResMed, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ResMed Inc. to Present at Upcoming Conferences
2. ResMed Inc Announces Record Financial Results for the Quarter and Six Months Ended December 31, 2009
3. ResMed Inc. Announces Record Financial Results for the Quarter Ended September 30, 2009
4. ResMed Acquires Laboratoires Narval
5. Trubion Announces Dates for Second-Quarter and First-Half 2010 Earnings Conference Call
6. Mylan Announces Completion of Add-On Offering of Senior Notes
7. Interleukin Genetics, Inc. Announces Conference Call to Discuss Second Quarter 2010 Results
8. ProUroCare Medical Inc. Announces Completion of Warrant Replacement Offering
9. Cornerstone Therapeutics Announces Development of Generic for Tussionex®
10. ViroPharma Announces Publication of Cinryze™ (C1 Esterase Inhibitor [Human]) Phase 3 Trial Results in Hereditary Angioedema (HAE) in the New England Journal of Medicine
11. Cytel Announces Compass® - The Only Professional Adaptive Trial Software Package for Bayesian or Frequentist Dose-Finding Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... Aug. 19, 2014 Research and Markets ... Drugs - Global Strategic Business Report" report to their ... for Human Growth Hormone Drugs in US$ Million by the ... The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ...
(Date:8/19/2014)... , Aug. 19, 2014  Boehringer Ingelheim ... Administration (FDA) accepted for review the New Drug ... tiotropium and olodaterol delivered via the Respimat ® ... once-daily maintenance treatment of airflow obstruction in patients ... bronchitis and/or emphysema. Tiotropium + olodaterol FDC will ...
(Date:8/19/2014)... Aug. 19, 2014  Stryker Corporation,s Orthopaedics Division, the Official ... is bringing its message of joint health to golf fans ... this week at The Barclays.  The company,s fan destination ... Spectator Village near the 17 th fairway at the ... on Thursday, August 21 st .    At ...
Breaking Medicine Technology:Global Human Growth Hormone Drugs - Strategic Business Report 2014 2Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 2Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 3Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 4Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 5Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 6Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 7Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 8Stryker, The Official Joint Replacement Products Of The PGA TOUR, Welcomes Golf Fans To Its Home State Of New Jersey For The Barclays 2Stryker, The Official Joint Replacement Products Of The PGA TOUR, Welcomes Golf Fans To Its Home State Of New Jersey For The Barclays 3Stryker, The Official Joint Replacement Products Of The PGA TOUR, Welcomes Golf Fans To Its Home State Of New Jersey For The Barclays 4Stryker, The Official Joint Replacement Products Of The PGA TOUR, Welcomes Golf Fans To Its Home State Of New Jersey For The Barclays 5
... 31, 2011 Boston Scientific Corporation (NYSE: ... Food and Drug Administration (FDA) has approved its ... and delivery of diagnostic, embolic and therapeutic materials ... be used by interventional radiologists for minimally invasive ...
... Endologix, Inc. (Nasdaq: ELGX ), ... announced today the publication of favorable clinical results ... of abdominal aortic aneurysm (EVAR).  The peer-reviewed article ... trial, with successful aneurysm exclusion in all patients, ...
Cached Medicine Technology:Boston Scientific Announces FDA Approval of Renegade® HI-FLO™ Fathom® Pre-Loaded System 2Boston Scientific Announces FDA Approval of Renegade® HI-FLO™ Fathom® Pre-Loaded System 3Boston Scientific Announces FDA Approval of Renegade® HI-FLO™ Fathom® Pre-Loaded System 4Endologix Announces Favorable Clinical Results for Nellix Technology 2Endologix Announces Favorable Clinical Results for Nellix Technology 3
(Date:8/20/2014)... NY (PRWEB) August 20, 2014 The ... PM360, a leading health-marketing industry trade magazine, will honor ... the Trailblazer Awards are given to outstanding companies, marketers ... to offer. , “We are proud to announce ... call to entries with double the number of submissions ...
(Date:8/20/2014)... Botanica Day Spa ... the new and popular stem cell line from ... and wrinkles and naturally repairs the skin. The ... new service by offering clients a complimentary dermaplaning ... facial. , Pevonia® continues to be a global ...
(Date:8/20/2014)... chosen by Plymouth University to be an official charity ... to raise awareness of, and funding for, scientific research ... patients. , A range of events and activities organised ... and members of staff and students, as well as ... and volunteer. The involvement of the wider community across ...
(Date:8/20/2014)... 2014 If old age is a disease ... it. With extensive research on HGH and stem cells technology, ... have perfected the art of rubbing off decades from your ... look with their revolutionary anti-aging hormone therapy and regenerative medicine. ... fountain of youth, the MD of MetroMD, Dr Alex Martin ...
(Date:8/20/2014)... Jersey (PRWEB) August 20, 2014 New ... the needs of an estimated tens of thousands of ... the new Bill A3525—a bill that would expand the ... grow their own cannabis—earlier this summer by State Assemblywoman ... for medicinal quality marijuana is growing. , To help ...
Breaking Medicine News(10 mins):Health News:PM360 Announces 2014 Trailblazer Award Finalists 2Health News:PM360 Announces 2014 Trailblazer Award Finalists 3Health News:PM360 Announces 2014 Trailblazer Award Finalists 4Health News:PM360 Announces 2014 Trailblazer Award Finalists 5Health News:PM360 Announces 2014 Trailblazer Award Finalists 6Health News:PM360 Announces 2014 Trailblazer Award Finalists 7Health News:PM360 Announces 2014 Trailblazer Award Finalists 8Health News:New Stem Cell Facial Unveiled at Botanica Day Spa 2Health News:New Stem Cell Facial Unveiled at Botanica Day Spa 3Health News:Plymouth University chooses Brain Tumour Research as official charity 2Health News:MetroMD Offers Revolutionary Anti-aging Hormone Therapy in Hollywood Area 2Health News:Oaksterdam University to Host Four-Day Educational Marijuana Horticultural Seminar Aug 23-26; Training Fills Information Gap for Medical Marijuana Caregivers and Patients 2Health News:Oaksterdam University to Host Four-Day Educational Marijuana Horticultural Seminar Aug 23-26; Training Fills Information Gap for Medical Marijuana Caregivers and Patients 3
... ... ways to make Obamacare palatable to Americans, a new poll conducted by ... which was conducted January 19-21, shows that an overwhelming majority of Americans ... versions of Obamacare. The Poll also finds that nearly all Americans ...
... NORTH HOLLYWOOD, Calif. , Feb. 2 IPC The Hospitalist Company, Inc. (Nasdaq: IPCM ), ... Bank 2010 Small and Mid Cap Conference held in Naples, FL.   , ... Jeff Taylor, President and COO, Date: ... 10:00 a.m. Eastern, Place: ...
... to inhaling nearly 3 more, study finds , TUESDAY, Feb. ... with directly inhaling cigarette smoke, smokers also face significant risk ... published online Jan. 29 in Environmental Health , challenges ... by secondhand smoke is negligible. , The study focused on ...
... ... distribution agreement to provide GuardRFID’s Active RFID platform to its Healthcare, Government and Industrial ... (PRWEB) ... VT Milcom of Virginia Beach, Va. to provide its next generation RFID platform to ...
... RANCHO CORDOVA, Calif. , Feb. 2 VSP ... eyewear through innovative business solutions and quality vision products, today ... financial officer. Ball will replace former vice president and CFO ... and report to chief executive officer, Rob Lynch . ...
... , New online hospital ratings put infection rates ... YONKERS, N.Y. , Feb. 2 Hospitals in ... of how well their intensive care units (ICUs) prevent central-line bloodstream infections, ... is largely preventable.  On February 2 , www.ConsumerReportsHealth.org will ...
Cached Medicine News:Health News:79% of Voters Say Obamacare Marriage Penalty "Unfair" 2Health News:79% of Voters Say Obamacare Marriage Penalty "Unfair" 3Health News:IPC The Hospitalist Company, Inc. to Present at Deutsche Bank 2010 Small and Mid Cap Conference 2Health News:Guard RFID Solutions Inc. and VT Milcom Enter into Distribution Agreement 2Health News:VSP Global Appoints New Chief Financial Officer 2Health News:Consumer Reports Health: Central-Line Infection Rates in Tampa-St. Petersburg Area Hospitals Vary Dramatically 2Health News:Consumer Reports Health: Central-Line Infection Rates in Tampa-St. Petersburg Area Hospitals Vary Dramatically 3Health News:Consumer Reports Health: Central-Line Infection Rates in Tampa-St. Petersburg Area Hospitals Vary Dramatically 4Health News:Consumer Reports Health: Central-Line Infection Rates in Tampa-St. Petersburg Area Hospitals Vary Dramatically 5Health News:Consumer Reports Health: Central-Line Infection Rates in Tampa-St. Petersburg Area Hospitals Vary Dramatically 6
... multifunction plate reader that offers four different ... time-resolved fluorescence, high-perfomance luminescence and absorbance. The ... that deliver reagent at the point of ... can be performed easily and allowing the ...
This new dedicated VICTOR2 model is for fluorescence and luminescence measurements....
... VICTOR2 multilabel counter with ... stacker and robot loading ... density time-resolved fluorescence, luminescence ... of the instrument is ...
This is the modular manually operated VICTOR2 multilabel counter, with the addition of a xenon flash lamp for time-resolved fluorescence counting. Along with this option comes flash absorbance and du...
Medicine Products: